Kinetics of silica nanoparticles in the human placenta

References

• Ala-Kokko TI, Myllynen P, Vähäkangas K. 2000. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int J Obstet Anesth 9:26–38
   Web of Science ®Google Scholar
• Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL. 2006. In vitro models for studying trophoblast transcellular transport. Methods Mol Med 122:225–239
   PubMedGoogle Scholar
• Buerki-Thurnherr T, von Mandach U, Wick P. 2012. Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier. Swiss Med Wkly 142:w13559
   PubMed Web of Science ®Google Scholar
• Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, et al. 2012. In vitro placental model optimization for nanoparticle transport studies. Int j nanomedicine 7:497–510
   PubMed Web of Science ®Google Scholar
• Chen Z-Z, Cai L, Dong X-M, Tang H-W, Pang D-W. 2012. Covalent conjugation of avidin with dye-doped silica nanopaticles and preparation of high density avidin nanoparticles as photostable bioprobes. Biosens Bioelectron 37:75–81
   PubMedGoogle Scholar
• Dusinska M, Fjellsbo LM, Heimstad E, Harju M, Bartonova A, Tran L, et al. 2009a. Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project. J Phys Conf Ser 170:012039
   Google Scholar
• Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, et al. 2009b. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (London) 4:605–607
   PubMed Web of Science ®Google Scholar
• Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, et al. 2009. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol in Vitro 23:697–703
   PubMed Web of Science ®Google Scholar
• Galagudza M, Korolev Postnov Naumisheva Uskov Grigorova et al. 2012. Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int J Nanomedicine 7:1671–1678
   PubMed Web of Science ®Google Scholar
• Ganesh N, Jayakumar R, Koyakutty M, Mony U, Nair SV. 2012. Embedded Silica Nanoparticles in Poly(Caprolactone) Nanofibrous Scaffolds Enhanced Osteogenic Potential for Bone Tissue Engineering. Tissue Eng Part A 18:1867–1881
   PubMed Web of Science ®Google Scholar
• Gonçalves AS, Macedo AS, Souto EB. 2012. Therapeutic nanosystems for oncology nanomedicine. Clin Transl Oncol 14:883–890
   PubMedGoogle Scholar
• Guadagnini R, Halamoda B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):13–24
   PubMed Web of Science ®Google Scholar
• Hondow N, Brydson R, Wang P, Holton MD, Brown MR, Rees P, et al. 2012. Quantitative characterization of nanoparticle agglomeration within biological media. J Nanopart Res 14:977
   Google Scholar
• Jaganathan H, Godin B. 2012. Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev 64:1800–1819
   PubMed Web of Science ®Google Scholar
• Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. 2012. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications. J Control Release 164:307–313
   PubMed Web of Science ®Google Scholar
• Larsen LG, Clausen HV, Andersen B, Græm N. 1995. A stereologic study of postmature placentas fixed by dual perfusion. Am J Obstet Gynecol 172:500–507
   PubMedGoogle Scholar
• Lee S, Yun H-S, Kim S-H. 2011. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32:9434–9443
   PubMed Web of Science ®Google Scholar
• Lesniak A, Fenaroli F, Monopoli MP, Åberg C, Dawson KA, Salvati A. 2012. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845–5857
   PubMed Web of Science ®Google Scholar
• Mamaeva V, Sahlgren C, Lindén M. 2012. Mesoporous silica nanoparticles in medicine—Recent advances. Adv Drug Deliv Rev; epub ahead of print
   PubMedGoogle Scholar
• Mathiesen L, Mose T, Mørck TJ, Nielsen JKS, Nielsen LK, Maroun LL, et al. 2010. Quality assessment of a placental perfusion protocol. Reprod Toxicol 30:138–146
   PubMed Web of Science ®Google Scholar
• Menjoge AR, Rinderknecht AL, Navath RS, Faridnia M, Kim CJ, Romero R, et al. 2011. Transfer of PAMAM dendrimers across human placenta: Prospects of its use as drug carrier during pregnancy. J Control Release 150:326–338
   PubMed Web of Science ®Google Scholar
• Mitra P, Audus KL. 2009. Expression and functional activities of selected sulfotransferase isoforms in BeWo cells and primary cytotrophoblast cells. Biochem Pharmacol 78:1475–1482
   PubMed Web of Science ®Google Scholar
• Mose T, Kjaerstad MB, Mathiesen L, Nielsen JB, Edelfors S, Knudsen L. 2008. Placental Passage of Benzoic acid, Caffeine, and Glyphosate in an Ex Vivo Human Perfusion System. J Toxicol Environ Health A 71:984–991
   PubMed Web of Science ®Google Scholar
• Mose T, Mortensen GK, Hedegaard M, Knudsen LE. 2007. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol 23:83–91
   PubMed Web of Science ®Google Scholar
• Myllynen P, Loughran M, Howard C, Sormunen R, Walsh A, Vähäkangas K. 2008. Kinetics of gold nanoparticles in the human placenta. Reprod Toxicol 26:130–137
   PubMed Web of Science ®Google Scholar
• Myllynen P, Mathiesen L, Weimer M, Annola K, Immonen E, Karttunen V, et al. 2010. Preliminary interlaboratory comparison of the ex vivo dual human placental perfusion system. Reprod Toxicol 30:94–102
   PubMedGoogle Scholar
• Mørck TJ, Sorda G, Bechi N, Rasmussen BS, Nielsen JB, Ietta F, et al. 2010. Placental transport and in vitro effects of Bisphenol A. Reprod Toxicol 30:131–137
   PubMed Web of Science ®Google Scholar
• Poulsen MS, Rytting E, Mose T, Knudsen LE. 2009. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol In Vitro 23:1380–1386
   PubMed Web of Science ®Google Scholar
• Rytting E, Ahmed MS. 2013. Fetal drug therapy. In: Mattison DR, Editor. Clinical pharmacology during pregnancy. London: Elsevier. pp. 55–72
   Google Scholar
• Rytting E, Bryan J, Southard M, Audus KL. 2007. Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells. Biochem Pharmacol 73:891–900
   PubMedGoogle Scholar
• Sandhiya S, Dkhar SA, Surendiran A. 2009. Emerging trends of nanomedicine - an overview. Fundam Clin Pharmacol 23:263–269
   PubMed Web of Science ®Google Scholar
• Saunders M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671–684
   PubMed Web of Science ®Google Scholar
• Shi J, Karlsson HL, Johansson K, Gogvadze V, Xiao L, Li J, et al. 2012. Microsomal Glutathione Transferase 1 Protects Against Toxicity Induced by Silica Nanoparticles but Not by Zinc Oxide Nanoparticles. ACS Nano 6:1925–1938
   PubMed Web of Science ®Google Scholar
• Slowing I, Viveroescoto J, Wu C, Lin V. 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278–1288
   PubMed Web of Science ®Google Scholar
• Stępnik M, Arkusz J, Smok-Pieniążek A, Bratek-Skicki A, Salvati A. Lynch I, Dawson KA, Gromadzińska J, de Jong WH, Rydzyński K, 2012. Cytotoxic effects in 3T3-L1 mouse and WI-38 human fibroblasts following 72hour and 7day exposures to commercial silica nanoparticles. Toxicol Appl Pharmacol 263:89–101
   PubMed Web of Science ®Google Scholar
• Syme MR, Paxton JW, Keelan JA. 2004. Drug transfer and metabolism by the human placenta. Clin pharmacokinet 43:487–514
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y, Yoshioka Y. 2011. Quantifying the biodistribution of nanoparticles. Nat Nanotechnol 6:755–755
   PubMedGoogle Scholar
• Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, et al. 2010. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect 118:432–436
   PubMed Web of Science ®Google Scholar
• Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, et al. 2011. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 6:321–328
   PubMed Web of Science ®Google Scholar